Biora Therapeutics, Inc. (BIORQ)
OTCMKTS · Delayed Price · Currency is USD
0.1900
+0.0200 (11.76%)
Jul 8, 2025, 9:30 AM EDT

Biora Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
Jul '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
13729374296-
Upgrade
Market Cap Growth
-63.86%24.98%-92.14%26.17%--
Upgrade
Enterprise Value
38108123477310-
Upgrade
Last Close Price
0.1913.5032.92522.501327.50-
Upgrade
PS Ratio
0.949183.1396.37299.751828.75-
Upgrade
PB Ratio
-0.01-0.36-0.29-4.40-2.77-
Upgrade
EV/Sales Ratio
42.6526878.38404.76382.911910.59-
Upgrade
Debt / Equity Ratio
-0.38-0.47-1.27-1.49-1.52-0.87
Upgrade
Asset Turnover
0.0400.000.010.001.32
Upgrade
Inventory Turnover
-----10.83
Upgrade
Quick Ratio
0.030.261.341.451.360.56
Upgrade
Current Ratio
0.050.301.641.601.740.74
Upgrade
Return on Assets (ROA)
-154.63%-99.04%-47.56%-55.95%-52.51%-80.30%
Upgrade
Return on Capital (ROIC)
---111.31%-151.02%-298.17%-693.16%
Upgrade
Earnings Yield
-3752.93%-337.89%-129.82%-66.19%-64.99%-
Upgrade
FCF Yield
-5497.85%-132.31%-221.86%-45.04%-57.25%-
Upgrade
Buyback Yield / Dilution
-159.11%-106.59%-98.51%-249.49%-463.47%-4.84%
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.